Marshall Wace
TDOC icon

Marshall Wace’s Teladoc Health TDOC Stock Holding History

Marshall Wace’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.4K Hold
3,000
– – ﹤0.01% 3066
2025
Q4 		$21K Buy
+3,000
New +$23.5K ﹤0.01% 2824

Other funds holding TDOC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace's TDOC Position: Q1 2026 in Review

Marshall Wace increased its Teladoc Health (TDOC) stake by 578% in Q1 2026, buying an estimated $2.01M and bringing the position to 419,574 shares worth $2.29M. The position accounts for ﹤0.01% of the portfolio, ranked #1710.

Marshall Wace first reported a position in TDOC in Q4 2020 and has held it in 14 quarters since. The position peaked at $112M in Q1 2022. 322 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Marshall Wace held 419,574 shares of Teladoc Health worth $2.29M as of Q1 2026.
  • Marshall Wace bought 357,650 Teladoc Health shares in Q1 2026, an estimated $2.01M.
  • Teladoc Health made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #1710 holding.
  • Marshall Wace first reported a position in Teladoc Health in Q4 2020 and has held it in 14 quarters since.
  • Marshall Wace's Teladoc Health position peaked at $112M in Q1 2022.
  • 322 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.